{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T16:07:10Z","timestamp":1788970030986,"version":"build-2803163510"},"reference-count":50,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","hpbonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["HPB"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.hpb.2026.06.008","type":"journal-article","created":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T22:26:11Z","timestamp":1781994371000},"page":"1250-1264","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Intention to treat outcomes following management of locally advanced pancreatic ductal adenocarcinoma with curative intent: single centre cohort study"],"prefix":"10.1016","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4757-053X","authenticated-orcid":false,"given":"Moath","family":"Alarabiyat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saad","family":"Rehman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2362-9218","authenticated-orcid":false,"given":"Peter L.","family":"Labib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Powell-Brett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lewis","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawn","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuk T.","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shivan","family":"Sivakumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Good","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3052-7527","authenticated-orcid":false,"given":"Soulat S.","family":"Raza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bobby","family":"Dasari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravi","family":"Marudanayagam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Bartlett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith J.","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Sutcliffe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adithya","family":"Pathanki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanns","family":"Jahnsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arul","family":"Suthananthan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Fong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mabel J.","family":"Teng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasvinder","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Candish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean","family":"Elyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Nagy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bibish","family":"Baburaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subhadeep","family":"Bose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mujtaba S.","family":"Khaja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Medy","family":"Tsalic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Talha","family":"Hafeez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mano","family":"Joseph","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marwah","family":"Rashid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Kunene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anirban","family":"Chatterjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Tween","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed","family":"Asghar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"McDonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly","family":"Weir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaynor","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Boyle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"toby Mullett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebekah","family":"Hart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxcine","family":"Riddell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charity","family":"Bullock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4864-189X","authenticated-orcid":false,"given":"Nikolaos","family":"Chatzizacharias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hpb.2026.06.008_bib1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.hpb.2026.06.008_bib2","article-title":"Locally advanced versus metastatic pancreatic cancer: two different diseases with two different treatment approaches?","volume":"2","author":"Cascinu","year":"2013","journal-title":"Chin Clin Oncol"},{"key":"10.1016\/j.hpb.2026.06.008_bib3","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1097\/SLA.0000000000002753","article-title":"Survival in locally advanced pancreatic cancer after neoadjuvant therapy and surgical resection","volume":"270","author":"Gemenetzis","year":"2019","journal-title":"Ann Surg"},{"key":"10.1016\/j.hpb.2026.06.008_bib4","doi-asserted-by":"crossref","first-page":"4352","DOI":"10.1245\/s10434-016-5373-2","article-title":"Systematic review of resection rates and clinical outcomes after FOLFIRINOX-Based treatment in patients with locally advanced pancreatic cancer","volume":"23","author":"Rombouts","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.hpb.2026.06.008_bib5","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1016\/j.ejso.2020.02.037","article-title":"Borderline or locally advanced pancreatic adenocarcinoma: a single center experience on the FOLFIRINOX induction regimen","volume":"46","author":"Garnier","year":"2020","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.hpb.2026.06.008_bib6","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/SLA.0000000000005666","article-title":"Early recurrence after resection of locally advanced pancreatic cancer following induction therapy: an international multicenter Study","volume":"278","author":"Seelen","year":"2023","journal-title":"Ann Surg"},{"key":"10.1016\/j.hpb.2026.06.008_bib7","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1056\/NEJMoa1011923","article-title":"Groupe Tumeurs Digestives of Unicancer; PRODIGE Intergroup. FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer","volume":"364","author":"Conroy","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hpb.2026.06.008_bib8","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/S1470-2045(16)00172-8","article-title":"FOLFIRINOX for locally advanced pancreatic cancer: a systematic review and patient-level meta-analysis","volume":"17","author":"Suker","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.hpb.2026.06.008_bib9","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26062620","article-title":"State of the art of immune checkpoint inhibitors in unresectable pancreatic cancer: a comprehensive systematic review","volume":"26","author":"Orlandi","year":"2025","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.hpb.2026.06.008_bib10","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.annonc.2023.08.009","article-title":"ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org. Pancreatic cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up","volume":"34","author":"Conroy","year":"2023","journal-title":"Ann Oncol"},{"key":"10.1016\/j.hpb.2026.06.008_bib11","unstructured":"National Comprehensive Cancer Network. Pancreatic Adenocarcinoma (Version 2.2025). https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/pancreatic.pdf."},{"key":"10.1016\/j.hpb.2026.06.008_bib12","doi-asserted-by":"crossref","DOI":"10.1186\/s12957-021-02238-x","article-title":"Vascular resection for locally advanced pancreatic ductal adenocarcinoma: analysis of long-term outcomes from a single-centre series","volume":"19","author":"Feo","year":"2021","journal-title":"World J Surg Oncol"},{"key":"10.1016\/j.hpb.2026.06.008_bib13","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.4143\/crt.2023.977","article-title":"Clinical outcomes of surgery after neoadjuvant chemotherapy in locally advanced pancreatic ductal adenocarcinoma","volume":"56","author":"Lee","year":"2024","journal-title":"Cancer Res Treat"},{"key":"10.1016\/j.hpb.2026.06.008_bib14","doi-asserted-by":"crossref","first-page":"6180","DOI":"10.1245\/s10434-024-15591-4","article-title":"Surgery for locally advanced pancreatic cancer following induction chemotherapy: a single-center experience","volume":"31","author":"Theijse","year":"2024","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.hpb.2026.06.008_bib15","doi-asserted-by":"crossref","first-page":"5038","DOI":"10.1245\/s10434-022-11503-6","article-title":"Optimizing indications for conversion surgery based on analysis of 454 consecutive Japanese cases with unresectable pancreatic cancer who received modified FOLFIRINOX or gemcitabine plus nab-paclitaxel: a single-center retrospective Study","volume":"29","author":"Ushida","year":"2022","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.hpb.2026.06.008_bib16","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1097\/MPA.0000000000001694","article-title":"Treatment strategies for the optimal management of locally advanced pancreatic adenocarcinoma with curative intent: a systematic review","volume":"49","author":"Attard","year":"2020","journal-title":"Pancreas"},{"key":"10.1016\/j.hpb.2026.06.008_bib17","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1245\/s10434-023-14650-6","article-title":"Dutch Pancreatic Cancer Group. Nationwide use and outcome of surgery for locally advanced pancreatic cancer following induction chemotherapy","volume":"31","author":"Stoop","year":"2024","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.hpb.2026.06.008_bib18","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","article-title":"The strengthening the reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"370","author":"von Elm","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.hpb.2026.06.008_bib19","series-title":"Dataset for the histopathological reporting of carcinomas of the pancreas, ampulla of Vater and common bile duct (G091)","author":"Campbell","year":"2019"},{"key":"10.1016\/j.hpb.2026.06.008_bib20","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1245\/s10434-017-6025-x","article-title":"8th edition of the AJCC cancer staging manual: pancreas and hepatobiliary cancers","volume":"25","author":"Chun","year":"2018","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.hpb.2026.06.008_bib21","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.surg.2017.09.012","article-title":"Locally advanced pancreas cancer: staging and goals of therapy","volume":"163","author":"Chatzizacharias","year":"2018","journal-title":"Surgery"},{"key":"10.1016\/j.hpb.2026.06.008_bib22","doi-asserted-by":"crossref","DOI":"10.1097\/AS9.0000000000000486","article-title":"Surgical outcomes following neoadjuvant treatment for locally advanced and borderline resectable pancreatic ductal adenocarcinoma","volume":"5","author":"Yeung","year":"2024","journal-title":"Ann Surg Open"},{"key":"10.1016\/j.hpb.2026.06.008_bib23","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1200\/JOP.2016.015818","article-title":"Evolution of the management of resectable pancreatic cancer","volume":"12","author":"Tsai","year":"2016","journal-title":"J Oncol Pract"},{"key":"10.1016\/j.hpb.2026.06.008_bib24","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/SLA.0000000000003284","article-title":"Factors predicting response, perioperative outcomes, and survival following total neoadjuvant therapy for Borderline\/Locally advanced pancreatic cancer","volume":"273","author":"Truty","year":"2021","journal-title":"Ann Surg"},{"key":"10.1016\/j.hpb.2026.06.008_bib25","doi-asserted-by":"crossref","first-page":"6147","DOI":"10.1245\/s10434-024-15579-0","article-title":"Long-Duration neoadjuvant therapy with FOLFIRINOX yields favorable outcomes for patients who undergo surgery for pancreatic cancer","volume":"31","author":"Miller","year":"2024","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.hpb.2026.06.008_bib26","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1097\/MPA.0000000000002215","article-title":"Can concurrent chemoradiotherapy add meaningful benefit in addition to induction chemotherapy in the management of borderline resectable and locally advanced pancreatic cancer?: a systematic review","volume":"52","author":"Saha","year":"2023","journal-title":"Pancreas"},{"key":"10.1016\/j.hpb.2026.06.008_bib27","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1001\/jama.2016.4324","article-title":"LAP07 trial group. Effect of chemoradiotherapy vs chemotherapy on survival in patients with locally advanced pancreatic cancer controlled after 4 months of gemcitabine with or without erlotinib: the LAP07 randomized clinical trial","volume":"315","author":"Hammel","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.hpb.2026.06.008_bib28","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1200\/JCO.19.02274","article-title":"Dutch pancreatic cancer group. Preoperative chemoradiotherapy versus immediate surgery for resectable and borderline resectable pancreatic cancer: results of the Dutch randomized phase III PREOPANC trial","volume":"38","author":"Versteijne","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.hpb.2026.06.008_bib29","doi-asserted-by":"crossref","first-page":"7713","DOI":"10.1002\/cam4.5523","article-title":"Neoadjuvant chemotherapy and radiotherapy outcomes in borderline-resectable and locally-advanced pancreatic cancer patients","volume":"12","author":"Botta","year":"2023","journal-title":"Cancer Med"},{"key":"10.1016\/j.hpb.2026.06.008_bib30","doi-asserted-by":"crossref","first-page":"3487","DOI":"10.1007\/s00423-022-02653-y","article-title":"IMAGE study group. Added value of 3T MRI and the MRI-halo sign in assessing resectability of locally advanced pancreatic cancer following induction chemotherapy (IMAGE-MRI): prospective pilot study","volume":"407","author":"Stoop","year":"2022","journal-title":"Langenbecks Arch Surg"},{"key":"10.1016\/j.hpb.2026.06.008_bib31","doi-asserted-by":"crossref","first-page":"4059","DOI":"10.1002\/cam4.3044","article-title":"Usefulness of 18 F-fluorodeoxyglucose positron emission tomography\/computed tomography for predicting the prognosis and treatment response of neoadjuvant therapy for pancreatic ductal adenocarcinoma","volume":"9","author":"Yokose","year":"2020","journal-title":"Cancer Med"},{"key":"10.1016\/j.hpb.2026.06.008_bib32","doi-asserted-by":"crossref","first-page":"5749","DOI":"10.1002\/cncr.27636","article-title":"Response of borderline resectable pancreatic cancer to neoadjuvant therapy is not reflected by radiographic indicators","volume":"118","author":"Katz","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.hpb.2026.06.008_bib33","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1007\/s11605-016-3265-1","article-title":"Preoperative therapy and pancreatoduodenectomy for pancreatic ductal adenocarcinoma: a 25-Year single-institution experience","volume":"21","author":"Cloyd","year":"2017","journal-title":"J Gastrointest Surg"},{"key":"10.1016\/j.hpb.2026.06.008_bib34","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.hpb.2019.06.012","article-title":"Induction chemotherapy in pancreatic cancer: CA 19-9 may predict resectability and survival","volume":"22","author":"Heger","year":"2020","journal-title":"HPB (Oxford)"},{"key":"10.1016\/j.hpb.2026.06.008_bib35","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.hpb.2018.01.001","article-title":"Added value of CA19-9 response in predicting resectability of locally advanced pancreatic cancer following induction chemotherapy","volume":"20","author":"van Veldhuisen","year":"2018","journal-title":"HPB (Oxford)"},{"key":"10.1016\/j.hpb.2026.06.008_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2020.188409","article-title":"Roles of CA19-9 in pancreatic cancer: Biomarker, predictor and promoter","volume":"1875","author":"Luo","year":"2021","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"10.1016\/j.hpb.2026.06.008_bib37","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1097\/SLA.0000000000001741","article-title":"Potential biomarkers in Lewis negative patients with pancreatic cancer","volume":"265","author":"Luo","year":"2017","journal-title":"Ann Surg"},{"key":"10.1016\/j.hpb.2026.06.008_bib38","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1097\/SLA.0000000000001850","article-title":"Locally advanced pancreatic cancer: neoadjuvant therapy with folfirinox results in resectability in 60% of the patients","volume":"264","author":"Hackert","year":"2016","journal-title":"Ann Surg"},{"key":"10.1016\/j.hpb.2026.06.008_bib39","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/bjc.2016.45","article-title":"Final analysis of a phase II study of modified FOLFIRINOX in locally advanced and metastatic pancreatic cancer","volume":"114","author":"Stein","year":"2016","journal-title":"Br J Cancer"},{"key":"10.1016\/j.hpb.2026.06.008_bib40","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.pan.2020.03.011","article-title":"Clinical staging in pancreatic adenocarcinoma underestimates extent of disease","volume":"20","author":"Chawla","year":"2020","journal-title":"Pancreatology"},{"key":"10.1016\/j.hpb.2026.06.008_bib41","doi-asserted-by":"crossref","first-page":"129","DOI":"10.5009\/gnl20312","article-title":"Four-Tier pathologic tumor regression grading System predicts the clinical outcome in patients who undergo surgical resection for locally advanced pancreatic cancer after neoadjuvant chemotherapy","volume":"16","author":"Ahn","year":"2022","journal-title":"Gut Liver"},{"key":"10.1016\/j.hpb.2026.06.008_bib42","doi-asserted-by":"crossref","first-page":"8360","DOI":"10.18632\/oncotarget.7073","article-title":"Toward targeted therapy in chemotherapy-resistant pancreatic cancer with a smart triptolide nanomedicine","volume":"7","author":"Wang","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.hpb.2026.06.008_bib43","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1136\/gutjnl-2015-309304","article-title":"Stromal biology and therapy in pancreatic cancer: a changing paradigm","volume":"64","author":"Neesse","year":"2015","journal-title":"Gut"},{"key":"10.1016\/j.hpb.2026.06.008_bib44","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-18636-w","article-title":"Phase I clinical trial repurposing all-trans retinoic acid as a stromal targeting agent for pancreatic cancer","volume":"11","author":"Kocher","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.hpb.2026.06.008_bib45","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0070340","article-title":"Pancreaticoduodenectomy combined with vascular resection and reconstruction for patients with locally advanced pancreatic cancer: a multicenter, retrospective analysis","volume":"8","author":"Gong","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.hpb.2026.06.008_bib46","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1002\/bjs.9222","article-title":"Planned versus unplanned portal vein resections during pancreaticoduodenectomy for adenocarcinoma","volume":"100","author":"Kim","year":"2013","journal-title":"Br J Surg"},{"key":"10.1016\/j.hpb.2026.06.008_bib47","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.hpb.2017.02.437","article-title":"Superior mesenteric artery (SMA) resection during pancreatectomy for malignant disease of the pancreas: a systematic review","volume":"19","author":"Jegatheeswaran","year":"2017","journal-title":"HPB (Oxford)"},{"key":"10.1016\/j.hpb.2026.06.008_bib48","doi-asserted-by":"crossref","first-page":"7205","DOI":"10.21037\/tcr-19-2421","article-title":"Distal pancreatectomy with en bloc celiac axis resection does not improve the R0 rate or median survival time of patients with locally advanced pancreatic cancer: a systematic review and meta-analysis","volume":"9","author":"Feng","year":"2020","journal-title":"Transl Cancer Res"},{"key":"10.1016\/j.hpb.2026.06.008_bib49","doi-asserted-by":"crossref","first-page":"4309","DOI":"10.1097\/JS9.0000000000000742","article-title":"Perioperative and long-term survival outcomes of pancreatectomy with arterial resection in borderline resectable or locally advanced pancreatic cancer following neoadjuvant therapy: a systematic review and meta-analysis","volume":"109","author":"Xue","year":"2023","journal-title":"Int J Surg"},{"key":"10.1016\/j.hpb.2026.06.008_bib50","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1002\/bjs.10221","article-title":"Outcomes after extended pancreatectomy in patients with borderline resectable and locally advanced pancreatic cancer","volume":"103","author":"Hartwig","year":"2016","journal-title":"Br J Surg"}],"container-title":["HPB"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1365182X26006647?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1365182X26006647?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T15:09:44Z","timestamp":1788966584000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1365182X26006647"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":50,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S1365182X26006647"],"URL":"https:\/\/doi.org\/10.1016\/j.hpb.2026.06.008","relation":{},"ISSN":["1365-182X"],"issn-type":[{"value":"1365-182X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intention to treat outcomes following management of locally advanced pancreatic ductal adenocarcinoma with curative intent: single centre cohort study","name":"articletitle","label":"Article Title"},{"value":"HPB","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hpb.2026.06.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2026 Published by Elsevier Ltd on behalf of International Hepato-Pancreato-Biliary Association Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}